GPT Healthcare IPO

 

GPT Healthcare Limited is one of the largest regional corporate healthcare organisations in Eastern India in terms of number of beds and hospitals according to the CRISIL Report they commissioned. GPT Healthcare IPO will hit the market in February 2022.

About GPT Healthcare

Under the “ILS Hospitals” brand, they operate a chain of mid-sized multispecialty hospitals in Eastern India that provide integrated healthcare services with a focus on secondary and tertiary care. They operate 4 multispecialty hospitals with an overall strength of 556 beds as of September 30, 2021.

Internal medicine and diabetology, nephrology (such as renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics and neonatology are just a few of the specialties and superspecialties they provide.

Journey

In the year 2000, they opened their first hospital in Salt Lake, Kolkata, with an initial capacity of 8 beds, which has since grown to 85 beds, comprising 17 beds in various ICUs and HDUs.

Their second hospital, a multi-specialty tertiary care centre in Agartala, Tripura, opened in 2011 with a capacity of 205 beds and 52 beds in multiple ICUs.

Their hospital in Dum Dum, Kolkata, which opened in 2013, has 150 beds, 51 of which are in various ICUs and HDUs, and is licenced to conduct renal transplants.

Their hospital in Howrah, West Bengal, is a greenfield tertiary care facility that opened in 2019 and has 116 beds, comprising 43 ICU beds.

Business Approach

Integrated diagnostic services and pharmacy are available at each of their facilities for their patients.

They intentionally focus on Eastern India’s comparatively underserved healthcare sector, where they have a thorough awareness of regional peculiarities, patient culture, and medical professionals’ mindsets, as well as a lack of access to high-quality, low-cost healthcare.

With 1,767 staff as of September 30, 2021, they strive to provide quality and economical healthcare to all of their patients.

As of September 30, 2021, they had 75 full-time consultants and 314 visiting consultants. Each of their hospitals is wholly owned and managed by a distinct professional management team.

GPT Healthcare IPO

GPT Healthcare Limited, headquartered in Mumbai has submitted Draft Red Herring Prospectus(DRHP) to Securities and Exchange Board of India(SEBI) for initial public offering (IPO) of INR 17.5 crores & 3,804,700 equity shares on 08 October 2021.

The offer includes fresh issue of INR 17.5 crores value equity shares and there is an offer for sale (OFS) of 3,804,700 equity shares by the promoters mentioned in the DRHP. They are not looking for any pre-IPO placement in this issue.

They are now waiting for approval from Securities and Exchange Board of India(SEBI) to float the initial public offering (IPO) in the market.

Financials Trends

Particulars	For the year/period ended ( in Cr.)
	30-Jun-21	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	334.85	317.18	308.45	257.66
Total Revenue	91.64	248.86	216.08	174.73
Profit After Tax	16.11	21.09	10.96	14.95

Basic and Diluted Earnings Per Share

Financial Period	Basic EPS (in INR)	Diluted EPS (in INR)	Weight
Financial Year 2021	2.64	2.64	3
Financial Year 2020	1.37	1.37	2
Financial Year 2019	1.87	1.87	1
Weighted Average	2.09	2.09
30 June 2021	2.02	2.02

Objects of the Issue

• Prepayment / repayment of all or a portion of the outstanding borrowings of the company to be availed on consolidated basis.
• To meet common corporate objectives.

Basis of the offer

They feel the following are among the qualitative aspects that go into determining the Offer Price:

• Well-positioned in under-served healthcare delivery markets in high-traffic areas with a high population density.
• Specialty and location mix are both diverse.
• Operating and financial success and expansion track record.
• Mid-sized hospitals yield a good rate of return on investment.
• Capacity to recruit, train, and retain qualified medical personnel.
• Qualified management and seasoned leadership.
• Patients and attendees benefit from clinical expertise and cost-effectiveness.

GPT Healthcare IPO Peer Comparison

S. No.	Face Value	Company Name	PE
1	5	Apollo Hospitals Enterprise Limited	405.15
2	10	Max Healthcare Institute Limited	-211.13
3	10	Fortis Healthcare Limited	-181.31
4	10	Narayana Hrudayalaya Limited	-716.86
5	10	Healthcare Global Enterprise Limited	-14.31
6	10	Krishna Institute of Medical Sciences Limited	43.52
7	10	Shalby Limited	44.38

Note:

1. From the NSE portal, the closing price of these equity shares on October 12, 2021.
2. All financial data for listed industry peers is consolidated (unless otherwise stated) and derived from the respective firm’s annual results/reports for the fiscal year ended March 31, 2021.

GPT Healthcare IPO Details

IPO Opening Date	February 2022
IPO Closing Date	February 2022
Issue Type	Book Building
Face Value	10 per share
IPO Price	0 to 0 per equity share
Market Lot	–
Min Order Quantity	–
Listing At	BSE, NSE
Issue Size	–
Fresh Issue	17.5 Crores
Offer for Sale	3,804,700 Equity shares

GPT Healthcare IPO Date

GPT Healthcare IPO opening date is February 2022, and the closing date is February 2022. The GPT Healthcare IPO issue may list in February 2022.

IPO Opening Date	February 2022
IPO Closing Date	February 2022
Basis of Allotment Date	February 2022
Initiation of Refunds	February 2022
Credit of Shares to Demat Account	February 2022
IPO Listing Date	February 2022

Basis of Allotment

Type	% of Offer	Basis of Allotment
Qualified Institutional Buyer	50	Roughly  equivalent
Non Institutional Investor	15	Roughly  equivalent
Retail	35	Minimum level of 1 lot, based on availability, for every shareholder.

GPT Healthcare IPO Allotment Status

Allotment of equity stocks subject to the Fresh Issue and transfer of the Promoter Selling Shareholders’ OFS Stocks to the winning Bidders subject to the Offer for Sale. Nevertheless, the status of the allotment has yet to be revealed.

Here, you can find the Allotment Status of GPT Healthcare IPO.

GPT Healthcare IPO GMP

GPT Healthcare IPO Grey Market Premium is 0. You can check out GMP of Other IPOs on below Links:

Date	GMP (in Rs)	Subject to Sauda	Kostak (in Rs)
February 2022
February 2022
February 2022
February 2022
February 2022
February 2022
February 2022
February 2022
February 2022
February 2022
February 2022
February 2022

Check Out the GMP of all Other IPOs

IPO Grey Market Premium

GPT Healthcare IPO Review

GPT Healthcare IPO review will depend on the price band which will be announced after SEBI approval. Whenever it will be announced we will update you regarding review of GPT Healthcare IPO is good or bad.

GPT Healthcare IPO Risk

• The COVID-19 epidemic has had and will continue to have an impact on their company operations.
• Their revenue is heavily reliant on their West Bengal hospitals.
• Some of the lands on which their hospital buildings & Registered Office are located are leased to them on a long-term and non-perpetual basis.
• Their debts, as well as the terms and circumstances enforced by their financing agreements, may limit their capacity to expand their business and have a negative impact on it.
• They might not be able to expand their activities to other parts of India, which would be detrimental to their business.
• As a result of providing healthcare services, they are subject to legal claims and regulatory measures.

Other Threats

• Their supplies and equipment are provided by third-party vendors and manufacturers.
• There has been no appraisal of the Offer’s items by any bank or financial organisation.
• They have engaged in related party transactions in the past and may do so again in the future.
• They may be exposed to risks related to the management of personal data, including medical information.
• They, their Promoters, Directors, and Group Companies are involved in a number of legal procedures, the outcome of which could have a major and negative impact on their business.
• Reforms in the healthcare industry, as well as the uncertainties surrounding pharmaceutical pricing and other issues, could have a negative impact on their business.

Presence

In Eastern India, where their hospital network is centred, there is a huge and growing need for high-quality, low-cost healthcare.

Due to their early-mover advantage, strategically located facilities, brand presence, extensive awareness of regional markets, and established track record, they are well-positioned to capitalise on the predicted growth in the healthcare industry in Eastern India and bordering states.

Their long-standing operations, high-quality medical care, and long-standing relationships with their doctors and other medical professionals have helped them establish a strong brand name in the locality, making them a preferred hospital for patients and visitors.

Certificates & Achievements

GPT Healthcare Limited has been awarded certifications and accolades by a number of domestic and international organisations, demonstrating their commitment to providing efficient and high-quality medical care.

The NABH has awarded their facilities in Dum Dum and Agartala accreditation for meeting NABH hospital standards.

In the sphere of medical testing, their Dum Dum Hospital has also been approved by NABL for conforming to ISO 15189:2012 standards.

Their Agartala Hospital is the only NABH-accredited hospital in Agartala, and among the only 5 NABH-accredited hospitals in North Eastern India. (According to the CRISIL report.)

ILS Hospitals IPO Brokerage views

• Yes Securities : Not Updated
• Choice Brokering: Not Updated
• Axis Securities: Not Updated
• IIFL Securities: Not Updated
• Trade swift: Not Updated
• Anand Rathi : Not Updated
• ICICI Securities: Not Updated

GPT Healthcare IPO Subscription Status

Date	Day	QIB	NII	Retail	Employees	Total Subscription
February 2022	1
February 2022	2
February 2022	3

Management

Their Managing Director, Dr. Om Tantia, is the creator of ILS Hospitals and a well-known name in the field of laparoscopic surgery.

He founded ILS Hospitals in the year 2000 with the objective of providing superior healthcare services in Eastern India. He has more than 4 decades of experience in minimal access surgery.

Dr. Om Tantia is a skilled surgeon who has served as president of the Association of Minimal Access Surgeons of India and has received numerous awards, including an honorary professorship from the Indian Medical Association.

The Surgical Review Corporation in the United States named him a “Surgeon of Excellence in Metabolic and Bariatric Surgery” in 2016.

Promoters

• GPT Sons Private Limited
• Dwarika Prasad Tantia
• Dr. Om Tantia
• Shree Gopal Tantia.

Promoter’s Holding

Pre Issue Share Holding	99.97%
Post Issue Share Holding

ILS Hospitals IPO Prospectus